Enovis (ENOV) EBIT Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Enovis | 1.25 Bn | 1.22 Bn | 365.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | -36.10% |
| Dec 31, 2025 | -24.18% |
| Oct 3, 2025 | -61.59% |
| Jul 4, 2025 | -27.83% |
| Apr 4, 2025 | -24.56% |
| Dec 31, 2024 | -55.99% |
| Sep 27, 2024 | -19.80% |
| Jun 28, 2024 | -25.11% |
| Mar 29, 2024 | -76.25% |
| Dec 31, 2023 | -17.24% |
| Sep 29, 2023 | -20.91% |
| Jun 30, 2023 | -18.32% |
| Mar 31, 2023 | -19.15% |
| Dec 31, 2022 | 16.52% |
| Sep 30, 2022 | -17.50% |
| Jul 1, 2022 | -39.78% |
| Apr 1, 2022 | -20.19% |
| Dec 31, 2021 | -18.19% |
| Oct 1, 2021 | -17.86% |
| Jul 2, 2021 | -16.45% |
| Apr 2, 2021 | 4.81% |
| Dec 31, 2020 | -41.60% |
| Oct 2, 2020 | 6.33% |
| Jul 3, 2020 | -15.45% |
| Apr 3, 2020 | -9.57% |
| Dec 31, 2019 | -3.06% |
| Sep 27, 2019 | -10.60% |
| Jun 28, 2019 | -15.37% |
| Mar 29, 2019 | -51.59% |
| Dec 31, 2018 | -25.87% |
| Sep 28, 2018 | -19.36% |
| Jun 29, 2018 | -16.46% |
| Mar 30, 2018 | -2.98% |
| Dec 31, 2017 | -27.22% |
| Sep 29, 2017 | 7.67% |
| Jun 30, 2017 | 3.06% |
| Mar 31, 2017 | 35.07% |
| Dec 31, 2016 | 58.00% |
| Sep 30, 2016 | 60.93% |
| Jul 1, 2016 | 34.33% |
| Apr 1, 2016 | 33.73% |
| Dec 31, 2015 | 18.68% |
| Sep 25, 2015 | 39.56% |
| Jun 26, 2015 | 81.32% |